VALEANT ISSUES NEW SHARES TO FINANCE B&L ACQUISITION’

Valeant Pharmaceuticals International Inc. on Monday said it has issued $2.3 billion worth of new shares to help pay for its acquisition of Bausch & Lomb Inc.
The stock issue includes 23.5 million shares priced at $85 each, and 3.5 million shares at the same price for the deal’s underwriter, Goldman Sachs & Co.

Leave a Reply